Epratuzumab's Mechanism of Action Featured in Blood, Official Journal of The ... MarketWatch Accompanying the article was an invited commentary by Dr. Ronald P. Taylor of the University of Virginia School of Medicine, who is a pioneer on studies of trogocytosis involving anti-B-cell antibodies, such as rituximab. In the article by Rossi and ... |
